Invivyd gets notice of Pemgarda EUA termination
Seeking Alpha ·
Invivyd ( IVVD ) received a notice from the U.S. Food and Drug Administration terminating the emergency use authorization for PEMGARDA, its monoclonal antibody for COVID-19 prevention, effective June 29, 2027. The termination follows the U.S. Department of Health and Human Services’ announcement of
DYAX Investor Sentiment
Bullish (Long) 62% · Bearish (Short) 38%
306 participants
Related News
- Wells Fargo on positive catalyst watch at J.P. Morgan ahead of Q2 earnings
- AI memory, chip stocks rise after last week's sell-off; Trump praises Dell
- Porsche cutting 4K German jobs
- Most and least shorted industrial stocks with market caps between $2B-$10B as of end-June
- Broadcom Stock Rises On New Apple Supply Deal
- Retiring in 2027? Here Are 3 Scenarios You Must Stress Test First.